| Primary |
| Drug Use For Unknown Indication |
45.1% |
| Product Used For Unknown Indication |
22.0% |
| Hypertension |
8.8% |
| Cardiac Failure |
4.0% |
| Essential Hypertension |
3.3% |
| Atrial Fibrillation |
3.1% |
| Diabetes Mellitus |
2.0% |
| Hypertension Arterial |
1.7% |
| Atrial Flutter |
1.0% |
| Hypercholesterolaemia |
1.0% |
| Anxiety |
0.9% |
| Depression |
0.9% |
| Haemolytic Uraemic Syndrome |
0.9% |
| Oedema |
0.9% |
| Prophylaxis |
0.9% |
| Hypothyroidism |
0.8% |
| Agitation |
0.7% |
| Arrhythmia |
0.7% |
| Asthma |
0.7% |
| Hypoglycaemia |
0.7% |
|
| Renal Failure Acute |
33.9% |
| Renal Failure |
10.7% |
| Hyponatraemia |
8.9% |
| Malaise |
4.5% |
| Vomiting |
4.5% |
| Interstitial Lung Disease |
3.6% |
| Overdose |
3.6% |
| Fall |
2.7% |
| Hepatitis |
2.7% |
| Renal Impairment |
2.7% |
| Rhabdomyolysis |
2.7% |
| Somnolence |
2.7% |
| Stevens-johnson Syndrome |
2.7% |
| Sudden Death |
2.7% |
| Weight Decreased |
2.7% |
| Confusional State |
1.8% |
| Death |
1.8% |
| Guillain-barre Syndrome |
1.8% |
| Hypokalaemia |
1.8% |
| Neuroleptic Malignant Syndrome |
1.8% |
|
| Secondary |
| Product Used For Unknown Indication |
36.5% |
| Drug Use For Unknown Indication |
23.1% |
| Hypertension |
14.2% |
| Cardiac Failure |
5.6% |
| Atrial Fibrillation |
3.8% |
| Type 2 Diabetes Mellitus |
2.0% |
| Oedema |
1.9% |
| Depression |
1.7% |
| Hypothyroidism |
1.4% |
| Hypercholesterolaemia |
1.3% |
| Haemolytic Uraemic Syndrome |
1.1% |
| Prophylaxis |
1.0% |
| Ill-defined Disorder |
0.9% |
| Essential Hypertension |
0.8% |
| Pain |
0.8% |
| Renal Failure |
0.8% |
| Infection |
0.8% |
| Lung Disorder |
0.8% |
| Anxiety |
0.8% |
| Hypertension Arterial |
0.7% |
|
| Renal Failure Acute |
24.8% |
| Renal Failure |
16.0% |
| Hyponatraemia |
9.5% |
| Thrombocytopenia |
6.2% |
| Vomiting |
5.0% |
| Toxic Skin Eruption |
3.6% |
| Toxic Epidermal Necrolysis |
3.3% |
| Oedema |
3.1% |
| Renal Tubular Necrosis |
3.1% |
| Rhabdomyolysis |
2.9% |
| Agranulocytosis |
2.6% |
| Hepatic Encephalopathy |
2.6% |
| Thrombocytopenic Purpura |
2.6% |
| Weight Decreased |
2.6% |
| Interstitial Lung Disease |
2.4% |
| Hypotension |
1.9% |
| Malaise |
1.9% |
| Pancytopenia |
1.9% |
| Septic Shock |
1.9% |
| Transaminases Increased |
1.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
28.0% |
| Product Used For Unknown Indication |
22.4% |
| Hypertension |
10.4% |
| Atrial Fibrillation |
6.6% |
| Cardiac Failure |
4.3% |
| Pain |
2.7% |
| Prophylaxis |
2.6% |
| Type 2 Diabetes Mellitus |
2.4% |
| Ill-defined Disorder |
2.4% |
| Renal Transplant |
2.3% |
| Thrombosis Prophylaxis |
2.1% |
| Diabetes Mellitus |
2.0% |
| Depression |
1.9% |
| Hepatitis C |
1.9% |
| Multiple Myeloma |
1.4% |
| Anxiety |
1.4% |
| Rheumatoid Arthritis |
1.4% |
| Arrhythmia |
1.3% |
| Cerebrovascular Accident Prophylaxis |
1.2% |
| Infection |
1.2% |
|
| Renal Failure Acute |
12.7% |
| Thrombocytopenia |
12.4% |
| Renal Failure |
10.8% |
| Vomiting |
8.7% |
| International Normalised Ratio Increased |
7.2% |
| Toxic Skin Eruption |
4.7% |
| Rectal Haemorrhage |
4.2% |
| Overdose |
3.5% |
| Subdural Haematoma |
3.5% |
| Weight Decreased |
3.4% |
| Hypoglycaemia |
3.2% |
| Rhabdomyolysis |
3.2% |
| Respiratory Distress |
3.0% |
| Sinusitis |
3.0% |
| Weight Increased |
3.0% |
| Malaise |
2.7% |
| Pyrexia |
2.7% |
| Rash Maculo-papular |
2.7% |
| Somnolence |
2.7% |
| Melaena |
2.6% |
|
| Interacting |
| Hypertension |
37.7% |
| Ill-defined Disorder |
10.9% |
| Drug Use For Unknown Indication |
9.8% |
| Atrial Fibrillation |
7.1% |
| Product Used For Unknown Indication |
5.5% |
| Respiratory Disorder |
5.5% |
| Bronchitis |
3.3% |
| Dyslipidaemia |
3.3% |
| Diabetes Mellitus |
2.7% |
| Cardiac Failure |
2.2% |
| Cardiac Failure Nos |
1.6% |
| Hypertension Arterial |
1.6% |
| Anxiety |
1.1% |
| Arrhythmia |
1.1% |
| Arthralgia |
1.1% |
| Dyspnoea |
1.1% |
| Embolism |
1.1% |
| Hypercholesterolaemia |
1.1% |
| Lymphoedema |
1.1% |
| Otitis Media Chronic |
1.1% |
|
| Renal Failure Acute |
28.3% |
| Hyponatraemia |
13.0% |
| Renal Failure |
10.9% |
| Renal Impairment |
8.7% |
| Vomiting |
8.7% |
| Orthostatic Hypotension |
6.5% |
| International Normalised Ratio Increased |
4.3% |
| Ventricular Tachycardia |
4.3% |
| Blood Creatinine Increased |
2.2% |
| Hypokalaemia |
2.2% |
| Hypotension |
2.2% |
| Myocardial Infarction |
2.2% |
| Rash |
2.2% |
| Syncope |
2.2% |
| Weight Decreased |
2.2% |
|
